US Stock MarketDetailed Quotes

GLTO Galecto

Watchlist
  • 3.940
  • -0.960-19.59%
Close Mar 26 16:00 ET
  • 3.990
  • +0.050+1.27%
Pre 08:42 ET
5.21MMarket Cap-0.21P/E (TTM)

About Galecto Company

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf J?rgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsg?rd Schambye in 2011 and is headquartered in Boston, MA.

Company Profile

SymbolGLTO
Company NameGalecto
Listing DateOct 29, 2020
Issue Price15.00
Founded2011
CEODr. Hans T. Schambye, M.D.,PhD
MarketNASDAQ
Employees5
Fiscal Year Ends12-31
Address75 State Street,Suite 100
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02109
Phone1-45-070-5210

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Hans T. Schambye, M.D.,PhD
  • Director, President and Chief Executive Officer
  • 965.12K
  • Lori Firmani
  • Interim Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Carl S. Goldfischer,M.D.
  • Chairman of the Board
  • 155.19K
  • Amit D. Munshi
  • Independent Director
  • 78.85K
  • Dr. Jayson Dallas, M.D.
  • Independent Director
  • 86.35K
  • Dr. David Shapiro, M.D.
  • Independent Director
  • 148.84K
  • Dr. Anne Prener, M.D.,PhD
  • Independent Director
  • 83.85K
  • Dr. Amy B. Wechsler, M.D.
  • Independent Director
  • --
  • Garrett Winslow
  • General Counsel and Corporate Secretary
  • 554.39K
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.